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Summary.-The binding of horseradish-peroxidase-labelled peanut lectin (HRP-
PNL) to cryostat sections oftonsil, lymphoma lymph nodes, reactive lymph nodes and
miscellaneous tumours demonstrated that PNL binds selectively to lymphocytes in
germinal centres. Lymph nodes from 21 patients with non-Hodgkin's lymphomas
were phenotyped as cell suspensions for PNL binding, and the following surface
markers: E rosetting, C3d, SIg, OK markers of T-cell subsets, Ig heavy-chain and
light-chain classes. There was a positive correlation between PNL binding and cells
with SIg and C3d receptors.4/5 cases ofcentroblastic/centrocytic follicular lymphoma
had a PNL+ SIg+ C3d+ phenotype. Both cases of centroblastic/centrocytic diffuse
lymphoma were PNL-. There was no correlation between PNL binding and heavy-
or light-chain Ig class. PNL binding and presence of C3d receptors were not always
positively correlated, indicating that follicular cells may be either PNL+ SIg+ C3d+
or PNL+ SIg+ C3d-. The binding pattern of PNL to 1 case of thymic hyperplasia and
2 cases of malignant lymphoma lymphoblastic T type suggested that some but not
all cortical thymocytes bind PNL.
THE LECTIN derived from the seeds of
the peanut plant Arachis hypogaea (peanut
lectin, PNL) binds to single terminal
galactose residues, but more avidly to the
disaccharide D-galactose 3' 1-3 D-N,
acetylgalactosamine (Pereira et al., 1976).
This sugar is part of the oligo-saccharide
array on cell surfaces, but it is commonly
covered by sialic acid. Thus PNL will not
bind to most lymphocytes unless they are
pre-treated with neuraminidase. However,
cortical thymocytes of mouse and man
(Reisner et al., 1976; 1979), small numbers
ofperipheral T cells in the mouse (London
et al., 1978; Roelants et al., 1979) and
germinal-centre lymphocytes of mouse
(Rose et al., 1]980) bind PNL without
neuraminidase treatment. Experiments
from this laboratory have also revealed
that horseradish peroxidase-labelled PNL
(HRP-PNL) binds to germinal-centre
lymphocytes in human tonsil (Rose &
Malchiodi, 1981). The selective binding of
PNL by human cortical thymocytes and
follicular lymphocytes prompted a search
for the PNL-binding characteristics of
lymphoblastic lymphomas of cortical T-
cell type, and of follicular lymphoma. In
this paper we describe the binding of
HRP-PNL to frozen sections of tonsil,
lymphoma lymph nodes, reactive lymph
nodes and some other non-lymphoid
tumours, and the binding of fluorescein-
isothiocyanate-labelled PNL (FITC-PNL)
to cell suspensions from various tissues
and non-Hodgkin's lymphomas. The
results confirm the restricted binding of
peanut lectin to subsets of B and T
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lymphocytes, anid illustrate its potential
use as a marker of follicular lymphoma, in
section or in cell suspensions.
MATERIALS AND METHODS
Surgical biopsy specimens of the lymnph
nodes studied ere ol)tained from patients
admitted to the Royal Marsden Hospital,
Fulham Road, London and Sutton, or the
Medical Oncology Unit, St Bartholomew's
Hospital, London. Conventional histological
diagnoses on paraffin-embedded sections
were performied by either Dr John Sloane
(Sutton) or by Dr A. E. Stansfeld (Bart's
Hospital).
Binding of HRP-PINTL to cryostat sections.
Blocks from unfixed surgical biopsy materials
were snap-frozen in liquid N2 and stored in
liquid N2 before use. Embedded (Ames TC
compound) frozen blocks w,ere cryostat-
sectioned at 4 ,um, and air-dried. HRP-PNL
(prepared as previously described by Rose
et at., 1980) was reacted with sections in a
concentration of 20 jug/ml in phosphate-
buffered saline (PBS, pH 7.2). The reaction
was allow-ed to proceed for 30 min at 20°C,
and w,as terminiated by wxashing sections x 3
in a large excess of PBS. Sites of fixation of
HRP-PNL ere identified by development
with 3,4,3',4' tetra-aminobiphenyl hydro-
chloride (B.D.H.).
Binldiny ofFITC-PNL to cell suspentsionis.
FITC-PNL wras prepared as previously
(lescribed (Rose et al.. 1980). Cell suspensions
fromn fresh surgical biopsy samples of lymph
nodes wAere prepared in RPMI 1640, washed
x 2. and cell concentration adjusted to
107/ml. 100 ,ul of cell suspension was mixed
with 10() ,ul of FITC-PNL in PBS at a con-
centr ation of20 jug/ml. The resulting mixture
wsras incubated at 4°C for 30 min and ashed
x 3 in a large excess of PBS.
Phenotypic analysis of cell suspensions.
Cell suspensions were analysed for content of
T and B cells by rosetting, and immuno-
fluorescence techniques using standardized
particle preparations and antisera as follo-ws:
T cells ws ere quantitated using E rosettes
(4 C). anti-HTLA (anti-human lymphocyte
antigen serum raised against monkey thymus
in rabbits, kindly provided by Drs M.
Greaves, M. Roberts and G. Janossy) and in
some instances monoclonal mouse antisera
against human T-cell subsets (OKT series
antisera Ortho diagnostics). B cells were
quantitated using surface immunoglobulin
(SIg) expression, with heteroantisera specific
for total immunoglobulin (Ig) (, y, a, 8
heavy chains), and class-specific anti-Ig sera
for [u, y, a, 8 heavy chains and K and A light
chains (Habeshaw et al., 1979). The expres-
sion of C3d receptors by lymphocytes was
assessed concurrently, as previously de-
scribed (Habeshaw et al., 1979). HLA and Ta
antigen expression was monitored with the
monoclonal antisera W6/32 (anti-HLA-ABC)
and Da2 (anti-HLA-D, Ia-like antigen).
The phenotyping results, histological diag-
nosis, and HRP-PNL binding on frozen
sections were all assessed independently, and
combined after completion of the series.
RESULTS
PNL binding to tonsil and reactive lymphoid
tissue
HRP-PNL was found to bind to the
membrane of lymphocytes present in
germinal centres, but not to the coronal
small lymphocytes of all the 10 tonsils
examined (Fig. 1). Whole-cell suspensions
from tonsil indicated 10-20% of FITC-
PNL-binding cells, whereas 25-40% ofthe
same cellpopulation wasSIg+ complement-
receptor-positive. The PNL-binding cell
populations found in reactive lymph nodes
are shown in Table I. Where follicular
hyperplasia was present, SIg+ C3d+ and
PNL-binding cells appeared together, sug-
gesting that follicular cells are SIg+
C3d+ PNL+. The SIg positivity indicates
that the cells concerned are B lympho-
cytes.
PNL binding to lynmphomtia lymiph-node
cells, reactive lymtph nodes and
miscellaneous tumours
Preliminary experiments examined the
binding of HRP-PNL to frozen sections
of a variety of malignant and non-
malignant tissue (Table II). PNL was
found to bind largely to lymphocytes of
follicular lymphoma and reactive lymph
nodes, and rarely to lymphocytes of other
lymphomas. The binding of HRP-PNL
to oat-cell sarcoma and rhabdomyosar-
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FIG. 1. Binding ofHRP-PNL to cryostat section oftonsil. GC =germinal centre; CO =corona. x 180.
TABLE I. PINL+ cells in reactive (non-neoplastic) lymph nodes
% of total viable cells
Patient Age Histology
JW 27 Follicular hyperplasia
CY 25 Follicular hyperplasia
BK 21 Follicular reaction
DHD 58 Sinus histiocytes
EJ 47 Reaction to mammary
dysplasia
CP 16 Non-specific reactive
follicular hyperplasia
GA 65 Follicular reaction
E C3d SIg+ PNL
30 37 45 20 FITC-PNL
18 40 40 17
33 24 42 +
58 11 o30 +
51 14 40 + HRP-PNL*
ND ND ND +
57 21 30 + J
* HRP-PNL oni cryostat sections. + is PNL+ lymphocytes; ± is lymphocytes PNL- but connective
tissue PNL+.
coma was seen as strong cytoplasmic stain-
ing, and distinct from the membrane
staining of PNL to lymphocytes. Cryostat
sections from PNL+ follicular lymphoma
show large areas of PNL-binding lympho-
cytes (Fig. 2). PNL was also found to bind
to follicular dendritic cells, connective
tissue and macrophages to varying degrees
in different lymphomas, but it is not
possible to say whether it was membrane
or cytoplasmic binding. Electron-micro-
scope studies have revealed HRP-PNL
binding to the membrane of lymphoblasts
from human tonsil (Lydyard & Birbeck,
personal communication) and the fact that
large numbers of FITC-PNL-binding cells
can be recovered in cell suspensions from
lymph nodes from patients with follicular
lymphoma demonstrates that the binding
of PNL to follicular lymphocytes is mem-
brane binding. Where possible, retrospec-
tive surface marking was established for
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TABLE II.-Binding of
frozen sections of lympA
cells, reactive lymph no
laneous tumours
Tumour
Hodgkin's lymplhoma
T-cell lymphoma
Reactive hyperplasia
Nodular follicular
lymphoma
Diffuse lymphoma
Other lymphomas an(l
tumourst
Wilms' tumour
N
exan
HRP-PNL to the lymphoma patients of this series
woma lymphnode (Table III).
odes and miscel- These results clearly justified a more
detailed study of the surface phenotype
No. associated with large numbers of PNL+
containing lymphocytes. FITC-PNL binding was
;0ne(l PNLo therefore undertaken on cell suspensions
nine(l cytes from lymphoid organs of a number of
8 1* other patients in conjunction with descrip-
3 7 tion by other markers (Table IV). The
results establish some interesting corre-
6 5 lates of PNL binding with histology and
0 o with phenotype.
14
1 CPt C'Tonly+ PIVL-lymphom,a8
* Small discrete germinal cenitre at edge of node.
t Oat-cell carcinoma an(l rhabdomyosarcoma.
I Carcinoma of the larynx, leg sarcoma, angio-
blastoma, breast carcinoma, "secondary" carcin-
oma, non-endemic Burkitt's lymphoma, immuno-
blastic sarcoma, undifferentiated sarcoma, meta-
static carcinoma, high-grade malignant lymphoma,
malignant lymphoma lymphocytic, reactive sinus
histiocytosis, oat-cell carcinoma, rhabdlomyo-
sarcoma.
CT =connective tissue.
None of the cells from the nodes or
blood of lymphocytic lymphoma patients
bound PNL. The single case of T CLL
(Patient EB) showed slight (8%) PNL
binding of lymph-node cells. Patient AB,
with MLL, who showed a phenotypic
profile of SIgA-positive B cells expressing
C3dreceptors, did not bindPNL, evidence
a~~~q~ .. . ...a emm.
FIG. - g ofHfl n fo a
FIG. 2.-Binding ofHRP-PNL to cryostat section oflymph node from a patient with CB/CC/F. x 140.
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TABLE III.-HRP-PNL positivity in lymphoma: retrospective correlation with surface
marking
Histology
CB/CC/F
CB/CC/D)
MLL
MLL
MLL
Plasmacytoma
MLHgU
E
34
12
28
5
4
64
C3d1
36
26
0
3
15
12
SIg
58
71
90
70
88
22
20
SIg class HR1'-PNL*
y/ K +
8 K -
/I K _
/I K _
8C K -
(X K + t
pC _
* Binlding to lymphocytes unless otherwise statedl.
t Connective tissue was especially positive.
MLIB =malignant lymphoma immunoblastic; MLHgU =maligniant lymplioma lighi-gra(le unclaisified;
MLCC =malignant lymphoma centrocytic; MLL =malignant lymphoma lympliocytic; ML/LB :B =malignant
lymphoma lymphoblastic B type; ML/LB :T =malignant lymphoma lymphoblastic T type; CB/CC/F =
centroblastic and centrocytic follicular; CB/CC/D =centroblastic and centrocytic diffuse; HD = Hodgkin's
(lisease; LP = lymphocyte predominant; ML/CC/SC =malignant lymphoma centrocytic small-cell;
TdT = terminal (leoxynucleotidyl transferase; pc= polyclonal.
TABLE IV.-Percentage of FITC-PNL lymphocytes in
withphenotype
Histology
CB/CC/F*
CB/CC/F + HD
CB/CC/F
CB/CC/F
CB/CC/F
CB/CC/Dj
CB/CC/D
ML/LB :B
ML/LB :B
MLIB
MLIB
MLCC
MLL
MLL
MLL
"T" CLL
IL/LB :T
31L/LBB:T
Plasmacytoma
Lennert's
lymphoma
ML/CC/SC
E
24
30
1
20
26
1
12
2
63
38
1
28
14
4
55
80
C3M SIg
76
35 37
41 70
39 30
12 66
7 98
26 71
50 80
3 97
16 32
9 55
34 88
0 70
2 80
44 94
2 3
4 4
70t I 1
4 15 22
80 7 6
12 13 84
malignant lymphoma-correlation
0/
SIg class FITC-PNL Biopsy
y only 3 Node
Pc 36 Node
x A 66 Node
(x 8 A20 Node
y,utA 70 Node
y it 8K 4 Blood
8 K 0 Node
i K 7 Node
/I 8 K 97 Node
tL y A 8 K 8 Node
y 8 K 0 Node
y a y 0 Node
/ K 0 Node
ayY K 1 Blood
0X K I Node
pc 8 Node
I Pleural
effusatel
0 Nodet
8 KCya K 45 Stomach
Pc 0 Node
0 Node
* Recurrent. t OKT6+, TdT+. I Leukaemic. Cy = Cytoplasmic.
For key to abbreviations, see Table III.
that the PNL-binding site cannot be the
same as the SIgA or C3d binding sites.
The 2 cases of T-cell lymphoblastic
lymphoma (KF, LT) (Table IV) did not
show PNL binding, though 80% of their
lymphocytes expressed thymic cortical-
lymphocyte antigen (OKT6+) and were
TdT+. This suggests that not all cortical
thymocytes bind PNL, a possibility which
is supported by the profile of a thymus
gland (Table V) where there is a dis-
crepancy between the number of cortical
thymocytes (84%) and the number of cells
binding PNL (46%o).
One case of immunoblastic lymphoma
(GC, Table IV) showed only small num-
bers (8%) of PNL-binding cells, though
some ofthe B cells in this patient expressed
C3d receptors. Patient MC (Table III)
with a similar profile to GC, also failed to
show PNL positivity of lymphocytes in
lymph-node sections stained with HRP-
l:atient
CC
SD
JB
HB
LOD
PMG
MIC
Age
19
47
25
62
59
48
2_3
l'atient
JY
JN
LP
GB
HS
SD
SD
CB
LF
GC
JB
LC
HB
JI
AB
EB
KF
LT
PMG
FS
FR
Age
37
66
34
53
69
47
47
9
21-
47
64
78
62
44
72
64
5
7
48
51
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0() Bill(illng
46
96 (H1TLA 90)
84
43
12
+
2. Cryostat sect'i(
HRP-P1NL (lefinite 'fOllieular" staining iII
eortex with groups otf l'NI,+ cells.
PNL. One lymnphoblastic lymphomia of B-
cell type (CB, Table IV) had only 7 o
lymphocytes binding FITC-PNL, despite
the presence of complement receptors on
most B lymphocytes. In Patient JY
(Table IV) with follicular lymphorna,
PNL-binding cells were not detected.
This biopsy sample was from a patient
treated for recurrent disease over 2 years.
Her phenotype was atypical in 2 previous
biopsy samples, the tumour cells lacked
C3d receptors and did not express light-
chain Ig.
In the single case of CB/CC/diffuse
lymphoma (SD, Tables III & IV) little or
no binding of PNL could be shown, either
by HRP-PNL in section, or by FITC-PNL
in suspension. This patient was leukaemic
in addition to showing nodal involvement,
and blood lymphocytes on 9 repeat tests
did not bind PNL. One centrocytic lym-
phoma (LC, Table IV) did not show
FITC-PNL positivity, though the SIg+
C3d+ phenotype characteristic of these
lesions (Habeshaw et al., 1979) was clearly
expressed.
PNYL+ lynmphomias
Clear positive binding of PNL was
found in 4/5 cases of follicular lymphoma
(CB/CC/F), in plasmacytoma, and in
lymphoblastic lymphoma ofB-cell type. In
each positive case studied in suspension,
the positivity ranged from 20% to 97°, of
the lymph-node cells. In tissue sections,
positivity in follicular lymphoma (CB/
CC/F) was restricted to the nodules, and
was not expressed on lymphocytes in
surrounding internodular tissue. All PNL+
follicular lymphomas showed a B-cell
profile (SIg+ C3d+) characteristic of this
lesion (Habeshaw et al., 1979). PNL posi-
tivity was also present in B lymphoblastic
lymphoma (LF, Table IV) in which com-
plement receptors were not expressed. No
obvious correlation between SIg isotype
and PNL binding could be established
from this series.
I)1SCUSSION
iDiscussion of these results centres
around the PNL reactivity of follicular
B-cell populations, and the usefulness of
FITC-PNL or HRP-PNL as markers in
malignant lymphoma.
It is clear from previous studies of
mouse and man that PNL binding is
expressed by cells of both T and B
lineage. In T cells, PNL binding is
restricted to cortical lymphocytes in
mouse and man, and to small numbers of
peripheral T cells in the mouse (London
et al., 1978). However, whereas PNL binds
to 80% of murine thymocytes, and histo-
logically this appears to correlate with
all cortical thymocytes (Rose & Malchiodi,
1981), the results presented here (Table
V) and other reports (Reisner et al., 1979)
suggest that PNL does not bind to all
cortical thymocytes in man.
Lymphocytes (presumptive B cells) in
germinal centres but not in the corona
bind PNL. This has been demonstrated in
mtouse (Rose et al., 1980) and here for
human tonsil and other lymph nodes.
Moreover, in the present series substantial
numbers of PNL+ cells were found con-
currently with similar numbers of Ig+
cells (Table IV). It is known that the
peripheral lymphoid tissue of unstimu-
lated mice contains <500 PNL+ cells,
and that Ig+ cells are PNL- (Newman &
Boss, 1980; Rose & Malchiodi, 1981).
However, in the mitotically active Peyer's
patches, which contain germinal centres
and 300o PNL+ cells, double-labelling
studies have revealed that 80% of the
PNL+ cells bear surface Ig (Rose &
TABLE V.-PNVL positivity in thymrus
1. Cell stuspel.si(ii
MI1arkers
FITC-INL
E rosettes
OKT6
HLA (XV6/32)
Ta (D)a2)
'TIT
Slu
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Malchiodi, 1981). It may be assumed that
in the present series of non-T-cell lym-
phomas the majority of PNL+ follicular
cells are also Ig+, and the question arises
whether such cells share the other folli-
cular phenotype of C3d positivity. It has
been shown in this paper that C3d posi-
tivity does not always correlate with PNL
positivity. It may be that PNL positivity
identifies only one of the follicular B-cell
subsets. This subset can present as a
SIg+ C3d- cell (as in Patient LF, Table
IV) or as a cell expressing C3d receptors
(as in Patients LP and GB, Table IV).
One unexpected feature was the un-
equivocal positivity of a case of plasma-
cytoma, in which the plasma-cell compo-
nent ofthe lesion was PNL+. Plasma cells,
like cortical thymocytes and germinal-
centre lymnphocytes, are not actively
recirculating lymphocytes. They may be
only temporarily sessile while in a certain
state of differentiation. We would like to
suggest that PNL may be a marker of
sessile lymphoid populations of T or B
class. This may have important implica-
tions in the prognosis of lymphoma, as
the tendency of PNL+ tumours to become
leukaemic should be less marked than for
PNL- tumours of equivalent phenotype.
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